[1] |
中华医学会外科学分会胃肠外科学组. 结直肠癌肝转移诊断和综合治疗指南(2016版) [J]. 中华消化外科杂志, 2016, 15(8):755-767.
|
[2] |
Esfahani S, Heidari P, Sheth R, et al. Non-invasive imaging of C-MET receptor for delineation of liver metastasis of colorectal cancer [J]. Journal of Nuclear Medicine, 2013, 54(2):300-305.
|
[3] |
中国抗癌协会大肠癌专业委员会专家组. 结直肠癌肝转移转化治疗中靶向药物合理应用的专家指导意见 [J]. 中华胃肠外科杂志, 2013, 16(10):1000-1004.
|
[4] |
林俊忠, 潘志忠. 结直肠癌肝转移外科治疗的争议 [J]. 中华胃肠外科杂志, 2013, 16(8):714-717.
|
[5] |
邢宝才. 结直肠癌肝转移的规范化治疗 [J]. 中华消化外科杂志, 2013, 12(6):413-416.
|
[6] |
Ter Voert EG, Heijmen L, de Wilt JH, et al. Reproducibility and biological basis of in vivo T(2)* magnetic resonance imaging of liver metastasis of colorectal cancer [J]. Magnetic Resonance in Medicine, 2013, 70(4):1145–1152.
|
[7] |
孙谊, 闫晓峦, 王崑, 等. 结直肠癌多发性肝转移手术切除的疗效 [J]. 中华肝胆外科杂志, 2014, 20(3):195-200.
|
[8] |
刘德军, 陈炜, 张斌, 等. 结直肠癌同时性肝转移手术时机的选择 [J]. 中华消化外科杂志, 2012, 11(3):294-295.
|
[9] |
胡俊杰, 周志祥, 梁建伟, 等. 结直肠癌同时性肝转移同期手术切除疗效分析 [J]. 中华肿瘤杂志, 2013, 35(1):63-66.
|
[10] |
盛勤松, 林才照, 严盛, 等. 手助腹腔镜结直肠癌肝转移一期同步切除术六例分析 [J]. 中华普通外科杂志, 2012, 27(12):982-984.
|
[11] |
周进学, 王凯, 李庆军, 等. 腹腔镜结直肠癌肝转移一期切除术的临床疗效 [J]. 中华消化外科杂志, 2016, 15(2):135-139.
|
[12] |
Chen Dong-liang, Wang Zhi-qiang, Zeng Zhao-lei, et al. Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression [J]. Hepatology, 2014, 60(2):598–609.
|
[13] |
Yuge R, Kitadai Y, Shinagawa K, et al. mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment [J]. American Journal of Pathology, 2015, 185(2):399-408.
|
[14] |
朱德祥, 任黎, 许剑民. 伴有同时性不可切除肝转移的结直肠癌患者治疗的思考 [J]. 中华胃肠外科杂志, 2013, 16(8):718-720.
|
[15] |
Weidle UH, Birzele F, Krüger A. Molecular targets and pathways involved in liver metastasis of colorectal cancer [J]. Clinical & Experimental Metastasis, 2015, 32(6):623-635.
|
[16] |
Kee JY, Ito A, Hojo S, et al. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model [J]. Oncology Reports, 2013, 29(3):975-982.
|
[17] |
王杉, 申占龙. 对我国结直肠癌肝转移治疗现状的思考 [J]. 中华胃肠外科杂志, 2012, 15(10):993-996.
|
[18] |
Enquist IB, Good Z, Jubb AM, et al. Lymph node-independent liver metastasis in a model of metastatic colorectal cancer [J]. Nature Communications, 2014, 5(5):3530.
|
[19] |
Zhang Y, Davis C, Ryan J, et al. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver [J]. Clinical & Experimental Metastasis, 2013, 30(7):903-904.
|
[20] |
Lee HS, Kim HO, Hong YS, et al. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery [J]. Journal of Nuclear Medicine, 2014, 55(4):582-529.
|
[21] |
Ye LC, Ren L, Qiu JJ, et al. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis [J]. Tumor Biology, 2015, 36(11):1-8.
|
[22] |
马宽生, 王青兵. 结直肠癌肝转移射频治疗的现状与进展 [J]. 中华消化外科杂志, 2016, 15(2):117-122.
|
[23] |
Lee H, Choi DW, Cho YB, et al. Recurrence pattern depends on the location of colon cancer in the patients with synchronous colorectal liver metastasis [J]. Annals of Surgical Oncology, 2014, 21(5):1641-1646.
|
[24] |
王青兵, 蒋家云, 谭运华, 等. 结直肠癌肝转移治疗10年随访:单中心120例分析 [J]. 中华肝胆外科杂志, 2015, 21(7):449-453.
|
[25] |
赵明, 王健鹏, 吴沛宏. 射频消融治疗结直肠癌肝转移的现状 [J]. 中华肿瘤杂志, 2011, 33(6):401-404.
|
[26] |
Maruyama T, Murata S, Nakayama K, et al. Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer [J]. Oncology Reports, 2013, 31(2):625-633.
|
[27] |
Lin Q, Tan HT, Lim TK, et al. iTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis [J]. Proteomics, 2014, 14(11):1434-1443.
|
[28] |
Chen H, Peng H, Liu W, et al. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis [J]. Surgery, 2015, 158(6):1704-1173.
|
[29] |
孙志强, 陈健, 黄志成, 等. 介入热化疗栓塞联合125I粒子植入治疗大肠癌肝转移的临床观察 [J]. 中华放射医学与防护杂志, 2016, 36(4):294-297.
|
[30] |
Nakayama N, Yamashita K, Tanaka T, et al. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis [J]. Clinical & Experimental Metastasis, 2016, 33(1):3-13.
|